GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.
Level 5 - mechanism / opinion, no new human data
Narrative review presenting mechanistic reasoning without new empirical data.
PubMed 12811640 · doi:10.1007/s00702-003-0826-8
What was done
The authors reviewed postmortem and animal pharmacological evidence examining the regulation of the 67 kDa isoform of glutamic acid decarboxylase (GAD67) by dopamine D2 and NMDA receptors to propose a pathophysiological model integrating GABAergic, dopaminergic, and glutamatergic theories of psychosis in schizophrenia and bipolar disorder.
What was found
The abstract reports no quantitative values. It states that brain GAD67 expression is consistently decreased in patients with schizophrenia and bipolar disorder. In animal models, GAD67 expression decreases following chronic (but not acute) D2 receptor stimulation and short-term NMDA receptor blockade, whereas chronic D2 receptor antagonism increases GAD67 expression. The authors conclude that clinical GAD67 reductions are not an artifact of antipsychotic medication and propose that resulting GABA deficits disinhibit glutamatergic transmission, driving psychosis via downstream AMPA receptor overactivation.
Why it matters
The paper provides a unifying mechanistic hypothesis positioning GAD67 as a central marker of psychosis liability across schizophrenia and bipolar disorder. It highlights interventions aimed at increasing GAD67 expression as potential novel therapeutic avenues.
Limits
The paper is a non-systematic narrative review and theoretical proposal with no primary human trial data or quantitative pooling. The abstract provides no sample sizes, effect sizes, or study selection criteria, and relies heavily on preclinical pharmacology that may not fully model human psychiatric disease.
Cited by
- supports GABA is synthesized from glutamate via glutamic acid decarboxylase, while glutamate is an excitatory neurotransmitter that activates AMPA and NMDA receptors.